These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 37904578)

  • 1. Primary Hyperoxaluria Screening and Monitoring: Quantitative Measurement of Plasma Oxalate by Gas Chromatography-Mass Spectrometry With High Sensitivity.
    Yazdanpanah M; Cameron J; Chappel C; Yuan L
    Ann Lab Med; 2024 May; 44(3):235-244. PubMed ID: 37904578
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Development and Validation of a New Gas Chromatography-Tandem Mass Spectrometry Method for the Measurement of Enrichment of Glyoxylate Metabolism Analytes in Hyperoxaluria Patients Using a Stable Isotope Procedure.
    van Harskamp D; Garrelfs SF; Oosterveld MJS; Groothoff JW; van Goudoever JB; Schierbeek H
    Anal Chem; 2020 Jan; 92(2):1826-1832. PubMed ID: 31867958
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluation of a high-performance liquid chromatography method for urinary oxalate determination and investigation regarding the pediatric reference interval of spot urinary oxalate to creatinine ratio for screening of primary hyperoxaluria.
    Shen Y; Luo X; Li H; Guan Q; Cheng L
    J Clin Lab Anal; 2021 Aug; 35(8):e23870. PubMed ID: 34097312
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Assay of plasma oxalate with soluble oxalate oxidase.
    Petrarulo M; Cerelli E; Marangella M; Cosseddu D; Vitale C; Linari F
    Clin Chem; 1994 Nov; 40(11 Pt 1):2030-4. PubMed ID: 7955374
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Quantification of oxalate by novel LC-MS/MS: assay development, validation and application in lumasiran clinical trials.
    Clausen VA; Cao KH; Gansner JM; Robbie GJ; Wu JT
    Bioanalysis; 2023 May; 15(9):481-491. PubMed ID: 37195004
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The determination of oxalate in haemodialysate and plasma: a means to detect and study 'hyperoxaluria' in haemodialysed patients.
    Wolthers BG; Meijer S; Tepper T; Hayer M; Elzinga H
    Clin Sci (Lond); 1986 Jul; 71(1):41-7. PubMed ID: 3709074
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Quantification of urinary oxalate by liquid chromatography-tandem mass spectrometry with online weak anion exchange chromatography.
    Keevil BG; Thornton S
    Clin Chem; 2006 Dec; 52(12):2296-9. PubMed ID: 17040957
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Plasma oxalate: comparison of methodologies.
    Stokes F; Acquaviva-Bourdain C; Hoppe B; Lieske JC; Lindner E; Toulson G; Vaz FM; Rumsby G
    Urolithiasis; 2020 Dec; 48(6):473-480. PubMed ID: 32472220
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lumasiran for Advanced Primary Hyperoxaluria Type 1: Phase 3 ILLUMINATE-C Trial.
    Michael M; Groothoff JW; Shasha-Lavsky H; Lieske JC; Frishberg Y; Simkova E; Sellier-Leclerc AL; Devresse A; Guebre-Egziabher F; Bakkaloglu SA; Mourani C; Saqan R; Singer R; Willey R; Habtemariam B; Gansner JM; Bhan I; McGregor T; Magen D
    Am J Kidney Dis; 2023 Feb; 81(2):145-155.e1. PubMed ID: 35843439
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Rapid liquid chromatography tandem mass-spectrometry screening method for urinary metabolites of primary hyperoxaluria.
    Woodward G; Pryke R; Hoppe B; Rumsby G
    Ann Clin Biochem; 2019 Mar; 56(2):232-239. PubMed ID: 30373392
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Endogenous Oxalate Production in Primary Hyperoxaluria Type 1 Patients.
    Garrelfs SF; van Harskamp D; Peters-Sengers H; van den Akker CHP; Wanders RJA; Wijburg FA; van Goudoever JB; Groothoff JW; Schierbeek H; Oosterveld MJS
    J Am Soc Nephrol; 2021 Dec; 32(12):3175-3186. PubMed ID: 34686543
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Monitoring method for pre- and post-liver transplantation in patients with primary hyperoxaluria type I.
    Inoue Y; Masuyama H; Ikawa H; Mitsubuchi H; Kuhara T
    J Chromatogr B Analyt Technol Biomed Life Sci; 2003 Jul; 792(1):89-97. PubMed ID: 12829001
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The quantitation of oxalate in amniotic fluid by ion-chromatography.
    Wandzilak TR; Hanson FW; Williams HE
    Clin Chim Acta; 1989 Nov; 185(2):131-7. PubMed ID: 2624994
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mass spectrometric-selected ion monitoring assay for an oxalate absorption test applying [13C2]oxalate.
    von Unruh GE; Langer MA; Paar DW; Hesse A
    J Chromatogr B Biomed Sci Appl; 1998 Sep; 716(1-2):343-9. PubMed ID: 9824249
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Phase 1/2 Study of Lumasiran for Treatment of Primary Hyperoxaluria Type 1: A Placebo-Controlled Randomized Clinical Trial.
    Frishberg Y; Deschênes G; Groothoff JW; Hulton SA; Magen D; Harambat J; Van't Hoff WG; Lorch U; Milliner DS; Lieske JC; Haslett P; Garg PP; Vaishnaw AK; Talamudupula S; Lu J; Habtemariam BA; Erbe DV; McGregor TL; Cochat P;
    Clin J Am Soc Nephrol; 2021 Jul; 16(7):1025-1036. PubMed ID: 33985991
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ion-chromatographic determination of plasma oxalate reexamined.
    Petrarulo M; Cerelli E; Marangella M; Maglienti F; Linari F
    Clin Chem; 1993 Mar; 39(3):537-9. PubMed ID: 8448873
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Determination of oxalic acid clearance and plasma concentration by radioisotope infusion. Results in a family with hyperoxaluria.
    Prenen JA; Boer P; Dorhout Mees EJ; Endeman HJ; Yoe OH
    Acta Med Scand; 1981; 209(1-2):87-91. PubMed ID: 7211493
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Simple, fast and inexpensive quantification of glycolate in the urine of patients with primary hyperoxaluria type 1.
    Boehm T; Martin-Higueras C; Friesser E; Zitta C; Wallner S; Walli A; Kovacevic K; Hubmann H; Klavins K; Macheroux P; Hoppe B; Jilma B
    Urolithiasis; 2023 Mar; 51(1):49. PubMed ID: 36920530
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Oxalate measurement in the picomol range by ion chromatography: values in fasting plasma and urine of controls and patients with idiopathic calcium urolithiasis.
    Schwille PO; Manoharan M; Rümenapf G; Wölfel G; Berens H
    J Clin Chem Clin Biochem; 1989 Feb; 27(2):87-96. PubMed ID: 2746168
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Modified enzyme-based colorimetric assay of urinary and plasma oxalate with improved sensitivity and no ascorbate interference: reference values and sample handling procedures.
    Wilson DM; Liedtke RR
    Clin Chem; 1991 Jul; 37(7):1229-35. PubMed ID: 1855295
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.